General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
Total
Series A, Preferred Stock
Series B, Preferred Stock
Common Stock
Additional Paid-In Capital
Stock Payable [Member]
Retained Earnings (Accumulated Deficit)
Noncontrolling Interest
Balance, shares at Mar. 31, 2019   5,000,000   301,758,293        
Balance, amount at Mar. 31, 2019 $ (2,856,986) $ 500 $ 0 $ 30,177 $ 38,335,782 $ 0 $ (41,223,445) $ 0
Issuance of shares under equity financing agreement, shares       14,744,646        
Issuance of shares under equity financing agreement, amount 1,774,000     $ 1,474 1,772,526      
Issuance of shares upon conversion, shares       63,239,585        
Issuance of shares upon conversion, amount 639,710     $ 6,323 633,386      
Reclass of derivative liability upon conversion or redemption of related convertible debentures 8,000       8,000      
Purchase of Series B Preferred shares, shares     2,250          
Purchase of Series B Preferred shares, amount 2,250,000   $ 0   2,250,000      
Beneficial conversion feature related to the Series B Preferred Shares 0       475,000   (475,000)  
Beneficial conversion feature 58,548       58,548      
Net loss (4,728,951)           (4,728,951) (82,101)
Common stock issued to consultant, amount 0              
Balance, shares at Mar. 31, 2020   5,000,000 2,250 379,742,524        
Balance, amount at Mar. 31, 2020 (2,937,780) $ 500 $ 0 $ 37,975 43,533,243 0 (46,427,396) (82,101)
Beneficial conversion feature related to the Series B Preferred Shares 0       293,000   (293,000)  
Net loss (478,967)           (477,072) (1,895)
Purchase of Series B Preferred shares, shares     1,250          
Purchase of Series B Preferred shares, amount 1,250,000   $ 0   1,250,000      
Series B PS Dividends in kind issued, shares     50          
Series B PS Dividends in kind issued, amount 56,458   $ 0   56,458      
Conversion of Series B PS to common stock, shares     (800) 33,569,730        
Conversion of Series B PS to common stock, amount 0   $ (0) $ 3,357 (3,357)      
Issuance of common stock upon conversion, shares       37,926,239        
Issuance of common stock upon conversion, amount 226,437     $ 3,793 222,644      
Common stock issued in Vista Warrant settlement, shares       17,500,000        
Common stock issued in Vista Warrant settlement, amount 610,000     $ 1,750 608,250      
Common stock issued to consultant, shares       1,250,000        
Common stock issued to consultant, amount 61,250     $ 125 61,125      
Reclass of derivative liability upon conversion or redemption of related convertible debentures, amount 205,000       205,000      
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement 90,000       90,000      
Dividends payable on Series B PS (144,792)           (144,792)  
Balance, shares at Jun. 30, 2020   5,000,000 2,750 469,988,493        
Balance, amount at Jun. 30, 2020 (1,062,394) $ 500 $ 0 $ 47,000 46,316,363 0 (47,342,260) (83,996)
Balance, shares at Mar. 31, 2020   5,000,000 2,250 379,742,524        
Balance, amount at Mar. 31, 2020 (2,937,780) $ 500 $ 0 $ 37,975 43,533,243 0 (46,427,396) (82,101)
Net loss (1,065,265)              
Common stock issued to consultant, amount 128,750              
Balance, shares at Sep. 30, 2020   5,000,000 1,696 531,023,743        
Balance, amount at Sep. 30, 2020 (215,012) $ 500 $ (0) $ 53,103 48,638,480 0 (48,821,413) (85,682)
Balance, shares at Mar. 31, 2020   5,000,000 2,250 379,742,524        
Balance, amount at Mar. 31, 2020 (2,937,780) $ 500 $ 0 $ 37,975 43,533,243 0 (46,427,396) (82,101)
Reclass of derivative liability upon conversion or redemption of related convertible debentures 205,000       205,000      
Purchase of Series B Preferred shares, shares     3,250          
Purchase of Series B Preferred shares, amount 3,250,000   $ 0   3,250,000      
Beneficial conversion feature related to the Series B Preferred Shares 0       1,335,000   (1,335,000)  
Net loss (3,580,454)           (3,580,454) (5,729)
Series B PS Dividends in kind issued, shares     115          
Series B PS Dividends in kind issued, amount 134,442   $ 0   134,442      
Conversion of Series B PS to common stock, shares     (5,008) 113,517,030        
Conversion of Series B PS to common stock, amount 0   $ 0 $ 11,351 (11,351)      
Issuance of common stock upon conversion, shares       39,735,626        
Issuance of common stock upon conversion, amount 551,021     $ 3,974 547,047      
Common stock issued in Vista Warrant settlement, shares       17,500,000        
Common stock issued in Vista Warrant settlement, amount 610,000     $ 1,750 608,250      
Common stock issued to consultant, amount 745,250              
Dividends payable on Series B PS (317,085)           (317,085)  
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement 90,000       90,000      
Common stock issued to consultant, shares       4,250,000        
Common stock issued to consultant, amount 745,250     $ 425 744,825      
Beneficial conversion feature related to the Series D Preferred Shares 6,050,000       6,050,000      
Amortization of beneficial conversion feature related to Series D Preferred Shares (1,720,833)           (1,720,833)  
Accretion on Series D Preferred shares (302,500)           (302,500)  
Commitment shares issued with Series D Preferred Shares, shares       6,000,000        
Commitment shares issued with Series D Preferred Shares, amount 0     $ 600 (600)      
Common stock to be issued as finder's fees related to asset acquisition 136,000         136,000    
Beneficial conversion feature related to convertible debenture 163,636       163,636      
Beneficial conversion feature related to the Series E Preferred Shares 1,721,000              
Balance, shares at Mar. 31, 2021   5,000,000 607 560,745,180        
Balance, amount at Mar. 31, 2021 311,604 $ 500 $ 0 $ 56,075 56,649,491 136,000 (53,683,268) (87,830)
Balance, shares at Jun. 30, 2020   5,000,000 2,750 469,988,493        
Balance, amount at Jun. 30, 2020 (1,062,394) $ 500 $ 0 $ 47,000 46,316,363 0 (47,342,260) (83,996)
Beneficial conversion feature related to the Series B Preferred Shares 0   $ 0   807,000   (807,000)  
Net loss (588,193)           (588,193) (1,686)
Purchase of Series B Preferred shares, shares     1,250          
Purchase of Series B Preferred shares, amount 1,250,000   $ 0   1,250,000      
Series B PS Dividends in kind issued, shares     65          
Series B PS Dividends in kind issued, amount 77,984       77,984      
Conversion of Series B PS to common stock, shares     (2,369) 58,521,249        
Conversion of Series B PS to common stock, amount 0   $ (0) $ 5,852 (5,852)      
Issuance of common stock upon conversion, shares       1,014,001        
Issuance of common stock upon conversion, amount 125,736     $ 101 125,635      
Common stock issued to consultant, shares       1,500,000        
Common stock issued to consultant, amount 67,500     $ 150 67,350      
Dividends payable on Series B PS (83,960)           (83,960)  
Balance, shares at Sep. 30, 2020   5,000,000 1,696 531,023,743        
Balance, amount at Sep. 30, 2020 (215,012) $ 500 $ (0) $ 53,103 48,638,480 0 (48,821,413) (85,682)
Balance, shares at Mar. 31, 2021   5,000,000 607 560,745,180        
Balance, amount at Mar. 31, 2021 311,604 $ 500 $ 0 $ 56,075 56,649,491 136,000 (53,683,268) (87,830)
Net loss (2,562,743)           (2,562,743)  
Conversion of Series B PS to common stock, shares     (262) 3,144,000        
Conversion of Series B PS to common stock, amount 0   $ 0 $ 314 (314)      
Issuance of common stock upon conversion, shares       1,329,246        
Issuance of common stock upon conversion, amount 421,486     $ 133 421,353      
Common stock issued to consultant, shares       125,000        
Common stock issued to consultant, amount 73,651     $ 13 48,738 24,900    
Beneficial conversion feature related to the Series E Preferred Shares 3,269,505       3,269,505      
Conversion of Series D PS to common stock, amount 0   $ 0 $ 43 (43)      
Conversion of Series D PS to common stock, shares       428,572        
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares       35,772,729        
Sale of common shares and warrants for cash, less offering costs and commitment shares, amount 17,277,123     $ 3,577 17,273,546      
Exercise of warrants related to the sale of common shares, shares       1,100,000        
Exercise of warrants related to the sale of common shares, amount 11,000     $ 110 10,890      
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity (1,000,000)       (3,087,830) 2,000,000   87,830
Common shares to be issued for Patent acquisition 5,000,000         5,000,000    
Exchange of Series D PS to Series E PS (3,258,189)           (3,258,189)  
Amortization of beneficial conversion feature related to Series E Preferred Shares (817,376)           (817,376)  
Redemption of Series D Preferred shares (2,534,758)           (2,534,758)  
Balance, shares at Jun. 30, 2021   5,000,000 345 602,644,727        
Balance, amount at Jun. 30, 2021 18,950,668 $ 500 $ 0 $ 60,266 74,585,336 7,160,900 (62,856,334) 0
Balance, shares at Mar. 31, 2021   5,000,000 607 560,745,180        
Balance, amount at Mar. 31, 2021 311,604 $ 500 $ 0 $ 56,075 56,649,491 136,000 (53,683,268) (87,830)
Net loss (5,412,378)              
Common stock issued to consultant, amount 122,926              
Balance, shares at Sep. 30, 2021   5,000,000 345 606,821,513        
Balance, amount at Sep. 30, 2021 19,210,511 $ 500 $ 0 $ 60,683 74,609,294 11,948,176 (67,408,142) 0
Balance, shares at Jun. 30, 2021   5,000,000 345 602,644,727        
Balance, amount at Jun. 30, 2021 18,950,668 $ 500 $ 0 $ 60,266 74,585,336 7,160,900 (62,856,334) 0
Net loss (2,849,635)           (2,849,635)  
Common stock issued to consultant, shares       62,500        
Common stock issued to consultant, amount 49,275     $ 6 24,369 24,900    
Amortization of beneficial conversion feature related to Series E Preferred Shares (1,341,948)           (1,341,948)  
Conversion of Series E PS to common stock, shares       4,114,286        
Conversion of Series E PS to common stock, amount 0     $ 411 (411)      
Common shares to be issued for Technical and Equipment Rights Agreement 4,762,376         4,762,376    
Revision of dividends payable on Series B Preferred Shares (See Note 2)             (182,639)  
Dividends payable on Preferred Shares             (177,586)  
Balance, shares at Sep. 30, 2021   5,000,000 345 606,821,513        
Balance, amount at Sep. 30, 2021 $ 19,210,511 $ 500 $ 0 $ 60,683 $ 74,609,294 $ 11,948,176 $ (67,408,142) $ 0